Bulletin
Investor Alert

June 16, 2020, 9:00 a.m. EDT

Stocks Hit 52-Week High: $SLP $STAA $MNTA

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Simulations Plus Inc. (SLP)
  • X
    Staar Surgical Co. (STAA)
  • X
    Momenta Pharmaceuticals Inc. (MNTA)

or Cancel Already have a watchlist? Log In

Jun 16, 2020 (The Market Signal via Comtex) -- The Market Signal was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/201655945/composite SLP -3.17% , /zigman2/quotes/200571300/composite STAA -1.43% or /zigman2/quotes/200094979/composite MNTA -2.56% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

https://themarketsignal.com/Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Simulations Plus received up to $400,000 FDA grant

https://themarketsignal.com/Free-Report/SLP

(Click link above or copy, paste and hit enter in your browser for your report)

The leading provider of modeling and simulation solutions for the consumer goods, chemicals and Pharma companies, Simulations Plus, Inc. /zigman2/quotes/201655945/composite SLP -3.17% hit a new 52-week high of $54.59. Last month, the company had received FDA grant for up to $400,000 over tenure of three years as a part of new funded cooperative agreement.

The grant was given to the company for developing pharmacokinetics/pharmacodynamics (PBPK/PD) approaches based physiologically, so as to facilitate support interspecies translation for GastroPlus(R)'s ocular drug delivery.

The company will make use of the grant for improvement of Ocular Compartmental Absorption and Transit

(TM)
(OCAT
(TM)
) model.

STAAR Surgical 's net sales up 8% in the first quarter

https://themarketsignal.com/Free-Report/STAA

(Click link above or copy, paste and hit enter in your browser for your report)

The company dedicated to ophthalmic surgery, STAAR Surgical Company /zigman2/quotes/200571300/composite STAA -1.43% hit a new 52-week high of $45.33. The company had reported its first quarter financial results for the period ending April 3, 2020. The company said that the net sales in the reported quarter went up 8% to $35.2 Million from a year before.

The ICL sales of company for the first quarter surged 5% to $29.3 Million, while the units' sales went up 9% from a year before.

The company reported its gross margin at 70.4% in Q1-2020 as against 74.2% in Q1-2019. The company ended the quarter with $110.9 Million cash and cash equivalents.

Momenta Pharmaceuticals announces positive top line results from ongoing study

https://themarketsignal.com/Free-Report/MNTA

(Click link above or copy, paste and hit enter in your browser for your report)

/zigman2/quotes/201655945/composite
US : U.S.: Nasdaq
$ 61.41
-2.01 -3.17%
Volume: 165,318
Aug. 14, 2020 4:00p
P/E Ratio
122.36
Dividend Yield
0.39%
Market Cap
$1.21 billion
Rev. per Employee
$317,196
loading...
/zigman2/quotes/200571300/composite
US : U.S.: Nasdaq
$ 46.99
-0.68 -1.43%
Volume: 653,834
Aug. 14, 2020 4:00p
P/E Ratio
297.78
Dividend Yield
N/A
Market Cap
$2.15 billion
Rev. per Employee
$260,956
loading...
/zigman2/quotes/200094979/composite
US : U.S.: Nasdaq
$ 29.14
-0.77 -2.56%
Volume: 833,806
Aug. 14, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$3.46 billion
Rev. per Employee
$577,015
loading...
/zigman2/quotes/201655945/composite
US : U.S.: Nasdaq
$ 61.41
-2.01 -3.17%
Volume: 165,318
Aug. 14, 2020 4:00p
P/E Ratio
122.36
Dividend Yield
0.39%
Market Cap
$1.21 billion
Rev. per Employee
$317,196
loading...
/zigman2/quotes/200571300/composite
US : U.S.: Nasdaq
$ 46.99
-0.68 -1.43%
Volume: 653,834
Aug. 14, 2020 4:00p
P/E Ratio
297.78
Dividend Yield
N/A
Market Cap
$2.15 billion
Rev. per Employee
$260,956
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.